{{Rsnum
|rsid=153091
|Gene=SHISA9
|Chromosome=16
|position=13160099
|Orientation=minus
|GMAF=0.2043
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=SHISA9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 58.4 | 37.2 | 4.4
| HCB | 73.7 | 25.5 | 0.7
| JPT | 63.7 | 32.7 | 3.5
| YRI | 48.3 | 42.9 | 8.8
| ASW | 57.9 | 40.4 | 1.8
| CHB | 73.7 | 25.5 | 0.7
| CHD | 83.5 | 16.5 | 0.0
| GIH | 57.4 | 33.7 | 8.9
| LWK | 59.1 | 37.3 | 3.6
| MEX | 69.0 | 31.0 | 0.0
| MKK | 59.0 | 36.5 | 4.5
| TSI | 65.7 | 31.4 | 2.9
| HapMapRevision=28
}}{{PMID|20195266|OA=1
}} gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 2 x 10^-6 for triglycerides as a result of [[perphenazine]] use

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}